Sava Infond’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$721K Hold
8,350
– – 0.04% 128
2026
Q2
$653K Sell
8,350
-2,330
-22% -$188K 0.05% 131
2026
Q1
$925K Sell
10,680
-580
-5% -$55.6K 0.13% 107
2025
Q4
$1.08M Buy
11,260
+1,060
+10% +$103K 0.15% 92
2025
Q3
$971K Sell
10,200
-2,300
-18% -$211K 0.14% 99
2025
Q2
$1.09M Hold
12,500
– – 0.17% 87
2025
Q1
$1.12M Hold
12,500
– – 0.21% 86
2024
Q4
$998K Buy
+12,500
New +$1.08M 0.18% 87

Other funds holding MDT

Sava Infond's MDT Position: Q3 2026 in Review

Sava Infond held its Medtronic (MDT) position steady in Q3 2026 at 8,350 shares worth $721K. The position accounts for 0.04% of the portfolio, ranked #128.

Sava Infond first reported a position in MDT in Q4 2024 and has held it in 8 quarters since. The position peaked at $1.12M in Q1 2025. 863 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Sava Infond held 8,350 shares of Medtronic worth $721K as of Q3 2026.
  • Sava Infond left its Medtronic share count unchanged in Q3 2026.
  • Medtronic made up 0.04% of Sava Infond's portfolio in Q3 2026, its #128 holding.
  • Sava Infond first reported a position in Medtronic in Q4 2024 and has held it in 8 quarters since.
  • Sava Infond's Medtronic position peaked at $1.12M in Q1 2025.
  • 863 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Sava Infond's 13F filing for Q3 2026, filed 28 Oct 2026.